Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells

Tamoxifen is still the most commonly used endocrine therapy drug for estrogen receptor (ER)-positive breast cancer patients and has an excellent outcome, but tamoxifen resistance remains a great impediment to successful treatment. Recent studies have prompted an anti-tumor effect of aspirin. Here, w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Cheng, Ran, Liu, Ya-Jing, Cui, Jun-Wei, Yang, Man, Liu, Xiao-Ling, Li, Peng, Wang, Zhan, Zhu, Li-Zhang, Lu, Si-Yi, Zou, Li, Wu, Xiao-Qin, Li, Yu-Xia, Zhou, You, Fang, Zheng-Yu, Wei, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444740/
https://ncbi.nlm.nih.gov/pubmed/28415819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16325
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados